{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:54:44Z","timestamp":1793166884622,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SFB) 1066"],"award-info":[{"award-number":["SFB) 1066"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["537070058"],"award-info":[{"award-number":["537070058"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jconrel.2025.113932","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:54:33Z","timestamp":1749038073000},"page":"113932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Designing and modeling nanomedicines towards image-guided drug delivery in hematological malignancies"],"prefix":"10.1016","volume":"384","author":[{"given":"Shiva","family":"Khorshid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Baumeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"De Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Tiboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Elsafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"von Stillfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Chatain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kiessling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Koschmieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Twan","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Casettari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros Marios","family":"Sofias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113932_bb0005","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.113932_bb0010","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.113932_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s44222-024-00154-9","article-title":"The mechanisms of nanoparticle delivery to solid tumours","volume":"2","author":"Nguyen","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2025.113932_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s44222-024-00203-3","article-title":"Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact","author":"Dasgupta","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2025.113932_bb0025","author":"Maeda"},{"key":"10.1016\/j.jconrel.2025.113932_bb0030","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines - lessons learned from successes and failures","volume":"52","author":"He","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2025.113932_bb0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2019.01.011","article-title":"Combinatorial nanocarriers against drug resistance in hematological cancers: opportunities and emerging strategies","volume":"296","author":"Ghosh","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113932_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-023-01460-2","article-title":"Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.113932_bb0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2018.08.034","article-title":"Nanomedicines for the treatment of hematological malignancies","volume":"287","author":"Deshantri","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113932_bb0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.drudis.2019.10.001","article-title":"Heterogeneous surface-modified nanoplatforms for the targeted therapy of haematological malignancies","volume":"25","author":"Kulkarni","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.113932_bb0055","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2702040","article-title":"Noble metal nanomaterials for the diagnosis and treatment of hematological malignancies","volume":"27","author":"Huang","year":"2022","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jconrel.2025.113932_bb0060","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1039\/D0BM00129E","article-title":"Nanomedicine-a promising therapy for hematological malignancies","volume":"8","author":"Huang","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.113932_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ddr.21399","article-title":"RGD peptide-based target drug delivery of doxorubicin nanomedicine","volume":"78","author":"Sun","year":"2017","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jconrel.2025.113932_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejpb.2022.07.015","article-title":"A microfluidic approach to fabricate sucrose decorated liposomes with increased uptake in breast cancer cells","volume":"178","author":"Khorshid","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.113932_bb0075","doi-asserted-by":"crossref","first-page":"39736","DOI":"10.1021\/acsami.2c06627","article-title":"Microfluidic manufacturing of liposomes: development and optimization by design of experiment and machine learning","volume":"14","author":"Rebollo","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.113932_bb0080","article-title":"Microfluidics for nano-drug delivery systems: from fundamentals to industrialization","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.113932_bb0085","article-title":"Microfluidic nanoparticles for drug delivery","volume":"18","author":"Liu","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.113932_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202106725","article-title":"Self-driving platform for metal nanoparticle synthesis: combining microfluidics and machine learning","volume":"31","author":"Tao","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113932_bb0095","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1039\/D0NA01051K","article-title":"Microfluidic synthesis of protein-loaded nanogels in a coaxial flow reactor using a design of experiments approach","volume":"3","author":"Whiteley","year":"2021","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.jconrel.2025.113932_bb0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jconrel.2020.08.031","article-title":"The use of design of experiments with multiple responses to determine optimal formulations for in vivo hepatic mRNA delivery","volume":"327","author":"Hashiba","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113932_bb0105","series-title":"Design of Experiments for Pharmaceutical Product Development","year":"2021"},{"key":"10.1016\/j.jconrel.2025.113932_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120464","article-title":"Microfluidics for nanomedicines manufacturing: an affordable and low-cost 3D printing approach","volume":"599","author":"Tiboni","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113932_bb0115","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/s41375-018-0295-6","article-title":"JAK2V617F but not CALR mutations confer increased molecular responses to interferon-\u03b1 via JAK1\/STAT1 activation","volume":"33","author":"Czech","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2025.113932_bb0120","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1021\/acsnano.5b02796","article-title":"Systemic gene silencing in primary T lymphocytes using targeted lipid nanoparticles","volume":"9","author":"Ramishetti","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113932_bb0125","series-title":"A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes","year":"2025"},{"key":"10.1016\/j.jconrel.2025.113932_bb0130","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.113932_bb0135","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","article-title":"Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction","volume":"17","author":"Punjani","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2025.113932_bb0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.omtm.2023.06.005","article-title":"Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues","volume":"30","author":"Chander","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2025.113932_bb0145","doi-asserted-by":"crossref","first-page":"960","DOI":"10.7150\/thno.9293","article-title":"Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography","volume":"4","author":"Gremse","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.113932_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.294","article-title":"A preclinical micro-computed tomography database including 3D whole body organ segmentations","volume":"5","author":"Rosenhain","year":"2018","journal-title":"Sci. Data"},{"key":"10.1016\/j.jconrel.2025.113932_bb0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7150\/thno.13624","article-title":"Imalytics preclinical: interactive analysis of biomedical volume data","volume":"6","author":"Gremse","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.113932_bb0160","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jconrel.2020.09.046","article-title":"Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles","volume":"328","author":"Biancacci","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113932_bb0165","series-title":"Polypropylene Chemical Compatibility Chart From ISM","author":"Williams","year":"2021"},{"key":"10.1016\/j.jconrel.2025.113932_bb0170","doi-asserted-by":"crossref","first-page":"2100109","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery","volume":"2","author":"Xu","year":"2022","journal-title":"Adv. Nanobiomed. Res."},{"key":"10.1016\/j.jconrel.2025.113932_bb0175","article-title":"Precise control of liposome size using characteristic time depends on solvent type and membrane properties","volume":"13","author":"Choi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113932_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12111095","article-title":"Manufacturing considerations for the development of lipid nanoparticles using microfluidics","volume":"12","author":"Roces","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113932_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51065-4","article-title":"Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems","volume":"9","author":"Elsana","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113932_bb0190","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","article-title":"Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review","volume":"85","author":"Hadinoto","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.113932_bb0195","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/IJN.S198353","article-title":"Lipid-polymer hybrid nanoparticles as a nextgeneration drug delivery platform: state of the art, emerging technologies, and perspectives","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113932_bb0200","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","article-title":"On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA","volume":"12","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113932_bb0205","series-title":"Design of Experiments forPharmaceutical Product Development","author":"SarwarBeg","year":"2021"},{"key":"10.1016\/j.jconrel.2025.113932_bb0210","series-title":"Liposomes Using the NanoAssemblr \u00ae Benchtop Instrument Process Parameters to Reproducibly Tune Size Create Transformative Medicines TM","author":"Brown","year":"2025"},{"key":"10.1016\/j.jconrel.2025.113932_bb0215","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jconrel.2022.06.017","article-title":"On the size-regulation of RNA-loaded lipid nanoparticles synthesized by microfluidic device","volume":"348","author":"Okuda","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113932_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/srep25876","article-title":"Liposome production by microfluidics: potential and limiting factors","volume":"6","author":"Carugo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113932_bb0225","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1021\/nn901676x","article-title":"Microfluidic mixing and the formation of nanoscale lipid vesicles","volume":"4","author":"Jahn","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113932_bb0230","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113932_bb0235","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.113932_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113932_bb0245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11095-022-03460-2","article-title":"Structure and function of cationic and Ionizable lipids for nucleic acid delivery","volume":"40","author":"Sun","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.113932_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061223","article-title":"Preparation of drug-loaded liposomes with multi-inlet vortex mixers","volume":"14","author":"Zheng","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.113932_bb0255","article-title":"Cellular uptake and retention of nanoparticles: insights on particle properties and interaction with cellular components","volume":"25","author":"Augustine","year":"2020","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.jconrel.2025.113932_bb0260","doi-asserted-by":"crossref","DOI":"10.1186\/1477-3155-12-5","article-title":"Engineered nanoparticles interacting with cells: size matters","volume":"12","author":"Shang","year":"2014","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.113932_bb0265","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bpj.2018.11.3134","article-title":"Quantitative analysis of the correlation between cell size and cellular uptake of particles","volume":"116","author":"Khetan","year":"2019","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2025.113932_bb0270","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/acsnano.9b04407","article-title":"Regulation of cell uptake and cytotoxicity by nanoparticle core under the controlled shape, size, and surface chemistries","volume":"14","author":"Bai","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113932_bb0275","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/etc.2470","article-title":"Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type","volume":"33","author":"Kettler","year":"2014","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.jconrel.2025.113932_bb0280","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-023-04905-6","article-title":"Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies","volume":"80","author":"Karagiannis","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2025.113932_bb0285","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ijc.2910180405","article-title":"Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia","volume":"18","author":"Klein","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.113932_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16051011","article-title":"Multiple myeloma derived extracellular vesicle uptake by monocyte cells stimulates IL-6 and MMP-9 secretion and promotes cancer cell migration and proliferation","volume":"16","author":"Sheridan","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2025.113932_bb0295","series-title":"Plasma Membrane Abundance Dictates Phagocytic Capacity and Functional Crosstalk In Myeloid Cells","author":"Winer","year":"2025"},{"key":"10.1016\/j.jconrel.2025.113932_bb0300","series-title":"High Interleukin-3 Concentrations Prime Murine Myeloid Progenitor Cells Towards Granulocytic Differentiation Correspondence to","author":"Hakobyan","year":"2025"},{"key":"10.1016\/j.jconrel.2025.113932_bb0305","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"M\u00e9ndez-Ferrer","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113932_bb0310","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3324\/haematol.2014.113852","article-title":"A hostel for the hostile: the bone marrow niche in hematologic neoplasms","volume":"100","author":"Krause","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jconrel.2025.113932_bb0315","series-title":"Targeting the Bone Marrow Niche in Hematological Malignancies","first-page":"155","author":"Verma","year":"2017"},{"key":"10.1016\/j.jconrel.2025.113932_bb0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1259\/bjr\/31542964","article-title":"Spleen in haematological malignancies: Spectrum of imaging findings","volume":"85","author":"Saboo","year":"2012","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.jconrel.2025.113932_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123551","article-title":"Progression of myeloproliferative neoplasms (MPN): diagnostic and therapeutic perspectives","volume":"10","author":"Baumeister","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.113932_bb0330","series-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","author":"Dilliard","year":"2025"},{"key":"10.1016\/j.jconrel.2025.113932_bb0335","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1021\/acs.nanolett.1c01353","article-title":"Scalable mRNA and siRNA lipid nanoparticle production using a parallelized microfluidic device","volume":"21","author":"Shepherd","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.113932_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-12100-z","article-title":"DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine\/drug delivery","volume":"12","author":"Nag","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.113932_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119266","article-title":"Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: a case study using protein-loaded liposomes","volume":"582","author":"Webb","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113932_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120826","article-title":"Microfluidic formulation of nanoparticles for biomedical applications","volume":"274","author":"Shepherd","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.113932_bb0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/2210303109666190807104437","article-title":"Microfluidic manufacture of solid lipid nanoparticles: a case study on tristearin-based systems","volume":"10","author":"Anderluzzi","year":"2019","journal-title":"Drug Deliv. Lett."},{"key":"10.1016\/j.jconrel.2025.113932_bb0360","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jpp\/rgac085","article-title":"The manufacturing of 3D-printed microfluidic chips to analyse the effect upon particle size during the synthesis of lipid nanoparticles","volume":"75","author":"Weaver","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.113932_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115187","article-title":"Image-guided drug delivery: biomedical and imaging advances","volume":"206","author":"Sofias","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.113932_bb0370","series-title":"A Nature-inspired Nanodelivery Platform for Gene Silencing in Hematopoietic Stem and Progenitor Cells","author":"Van Der Meel","year":"2023"},{"key":"10.1016\/j.jconrel.2025.113932_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400225","article-title":"Branched-tail lipid nanoparticles for intravenous mRNA delivery to lung immune, endothelial, and alveolar cells in mice","volume":"13","author":"Petersen","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.113932_bb0380","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307801120","article-title":"Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart","volume":"121","author":"Radmand","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.113932_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1394443","article-title":"Acute myeloid leukemia cells adhere to bone marrow and acquire chemoresistance by downregulating UNC5B expression","volume":"14","author":"Teng","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2025.113932_bb0390","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.113932_bb0395","author":"Breda"},{"key":"10.1016\/j.jconrel.2025.113932_bb0400","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","article-title":"In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles","volume":"23","author":"Shi","year":"2023","journal-title":"Nano Lett."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925005528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:50:39Z","timestamp":1779511839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925005528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":80,"alternative-id":["S0168365925005528"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113932","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing and modeling nanomedicines towards image-guided drug delivery in hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113932"}}